Skip to content
10-Q

Quarterly Report

Keros Therapeutics, Inc. KROS

0001664710-25-000089

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 30.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 40.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 37.59M sh
Shares Diluted Q3 2025 · Sep 30, 2024 36.46M sh
Capex Q3 2025 · Sep 30, 2025 $1.42M
Capex Q3 2025 · Sep 30, 2024 $1.64M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $134.8M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$114.86M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $693.47M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $559.93M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $530.68M
Stockholders Equity Q3 2025 · Sep 30, 2025 $703.58M
Stockholders Equity Q3 2025 · Jun 30, 2025 $706.73M
Stockholders Equity Q3 2025 · Mar 31, 2025 $728.87M
Stockholders Equity Q3 2025 · Dec 31, 2024 $571.55M
Stockholders Equity Q3 2025 · Sep 30, 2024 $532.84M
Stockholders Equity Q3 2025 · Jun 30, 2024 $420.92M
Stockholders Equity Q3 2025 · Mar 31, 2024 $453.95M
Stockholders Equity Q3 2025 · Dec 31, 2023 $332.21M
Current Liabilities Q3 2025 · Sep 30, 2025 $24.09M
Current Liabilities Q3 2025 · Dec 31, 2024 $27.45M
Total Liabilities Q3 2025 · Sep 30, 2025 $39.2M
Total Liabilities Q3 2025 · Dec 31, 2024 $44.33M
Current Assets Q3 2025 · Sep 30, 2025 $719.31M
Current Assets Q3 2025 · Dec 31, 2024 $588.89M
Total Assets Q3 2025 · Sep 30, 2025 $742.78M
Total Assets Q3 2025 · Dec 31, 2024 $615.89M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2025 $2.68
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.41
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.88
Eps Basic Q3 2025 · Sep 30, 2025 −$0.18
Eps Basic Q3 2025 · Sep 30, 2025 $2.72
Eps Basic Q3 2025 · Sep 30, 2024 −$1.41
Eps Basic Q3 2025 · Sep 30, 2024 −$3.88
Sga Expense Q3 2025 · Sep 30, 2025 $10.13M
Sga Expense Q3 2025 · Sep 30, 2025 $35.11M
Sga Expense Q3 2025 · Sep 30, 2024 $9.82M
Sga Expense Q3 2025 · Sep 30, 2024 $30.09M
Rd Expense Q3 2025 · Sep 30, 2025 $19.52M
Rd Expense Q3 2025 · Sep 30, 2025 $111.73M
Rd Expense Q3 2025 · Sep 30, 2024 $49.23M
Rd Expense Q3 2025 · Sep 30, 2024 $128M
Net Income Q3 2025 · Sep 30, 2025 −$7.28M
Net Income Q3 2025 · Sep 30, 2025 $110.48M
Net Income Q3 2025 · Jun 30, 2025 −$30.7M
Net Income Q3 2025 · Mar 31, 2025 $148.45M
Net Income Q3 2025 · Sep 30, 2024 −$52.96M
Net Income Q3 2025 · Sep 30, 2024 −$141.33M
Net Income Q3 2025 · Jun 30, 2024 −$45.26M
Net Income Q3 2025 · Mar 31, 2024 −$43.11M
Operating Income Q3 2025 · Sep 30, 2025 −$15.38M
Operating Income Q3 2025 · Sep 30, 2025 $96.84M
Operating Income Q3 2025 · Sep 30, 2024 −$58.66M
Operating Income Q3 2025 · Sep 30, 2024 −$157.58M
Revenue Q3 2025 · Sep 30, 2025 $14.26M
Revenue Q3 2025 · Sep 30, 2025 $243.68M
Revenue Q3 2025 · Sep 30, 2024 $388K
Revenue Q3 2025 · Sep 30, 2024 $508K